查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379033

2023-2028 年按應用（糖尿病、肥胖、心血管疾病、中樞神經系統疾病、呼吸系統疾病、戒菸等）、最終用途（患者、提供者、付款人、雇主等）和地區分類的數位治療市場報告

Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球數位治療市場規模達到50億美元。展望未來， IMARC Group預計到2028年市場規模將達到150億美元，2022-2028年複合年成長率（CAGR）為20.1%。對數位行為監測治療的需求不斷成長、慢性病盛行率不斷上升以及大眾對個人健康和健身意識的不斷提高是推動市場的關鍵因素之一。

智慧型手機和平板電腦使用量的增加推動市場成長

對智慧型手機和平板電腦的日益依賴，加上不同的醫療保健應用程式，正在推動數位治療市場的成長。智慧型手機和基於平板電腦的醫療保健應用程式具有降低用藥錯誤率、促進預防性護理和更準確的人員配置等眾多優勢。個人科技設備在醫療保健領域的使用不斷增加，刺激了對數位療法 (DTx) 治療的需求。 DTx 正在增強患者獲得治療的安全性和有效性，以不同語言呈現訊息，提供有關疾病和治療的相關資訊，並擴大醫生護理患者的能力。此外，它是一種先進的護理服務模式，可以在家中輕鬆實施，並消除與傳統療法相關的任何恥辱。

數位治療市場趨勢：

報告涵蓋了市場結構、主要參與者的市場佔有率、參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。市場結構適度分散，有大量全球和區域參與者。此外，由於研發（R＆D）創新和併購（M＆A）數量的增加，該市場的競爭環境正在加劇。由於市場結構分散、產品差異化和轉換成本較低，數位治療行業的新進入者數量適中。此外，行動醫療開發商數量的不斷增加也加劇了新進入者的巨大威脅。然而，先進技術的專利要求和高成本以及嚴格的監管程序減少了新進入者的威脅。

什麼是數位治療？

數位療法 (DTx) 是一種由高品質軟體程式驅動的實證治療介入措施，用於預防、管理或治療醫學病症或疾病。它是軟體即醫療設備 (SaMD) 的一種形式，依靠軟體介入來改變患者的行為並幫助治療他們的病情。 DTx 是一類快速且新興的療法，利用軟體獨立治療疾病或最佳化治療。它有助於預防和管理多種疾病和病症，如2 型糖尿病、充血性心臟衰竭、肥胖、阿茲海默症、失智症、氣喘、藥物濫用、注意力不足過動症(ADHD)、高血壓、焦慮、憂鬱、和其他幾個。 DTx 還有助於提高患者用藥依從性，並支持醫療保健專業人員 (HCP) 以數位方式管理患者和業務。

COVID-19 影響：

COVID-19大流行的到來可謂醫療保健產業的分水嶺。它極大地改變了醫療保健提供的方式，同時暴露了世界各國政府在充分應對全球醫療保健緊急情況方面缺乏準備。第一線衛生工作者參與管理 COVID-19 患者，但患有其他健康問題的患者，尤其是慢性健康問題的患者，由於推遲或避免去診所就診，因此遇到了困難。此外，由於患有合併症（尤其是肥胖、心臟併發症和糖尿病）的患者中的 COVID-19 結局比沒有合併症的患者更差，因此要求這些患者額外保持警惕。這場大流行也帶來了相當一部分精神健康障礙，包括憂鬱、焦慮和戒斷，由於缺乏面對面的就診，這些疾病的管理是一個挑戰。這些相互關聯的事件促使醫療保健提供者尋求數位健康解決方案來應對健康危機。在 COVID-19 爆發期間，數位醫療技術的採用出現了積極的趨勢，提高了醫療保健營運和服務提供的效率和有效性。疫情發生後，DTx應用在各領域的採用加速了數倍。此外，COVID-19 大流行透過改變患者參與度和整合整個醫療保健領域的資料，增加了虛擬和家庭護理技術的採用。

數位治療市場趨勢：

目前，2 型糖尿病患者對 DTx 的需求不斷增加，以控制疾病並使他們能夠使用支援物聯網 (IoT) 的胰島素幫浦和其他健康監測系統。再加上對數位行為監測治療的需求不斷成長，以確保藥物依從性和健康生活方式的改變，這是支持市場成長的關鍵因素之一。此外，與傳統治療相比，擴大使用 DTx 來減少更多後續檢查和復發的需要，這提供了良好的市場前景。此外，心臟病、中風、癌症、肥胖和關節炎等慢性疾病的盛行率也在增加。再加上大眾對個人健康和健身意識的不斷提高，正在推動市場的成長。此外，對 DTx 的需求不斷成長，以幫助醫生管理患者對醫療方案的依從性，並建立一個綜合的健康生態系統，使資料能夠在付款人、提供者和藥房等不同利益相關者之間無縫傳輸，這正在推動市場的成長。

本報告回答的關鍵問題

  • 2022 年全球數位治療市場規模有多大？
  • 2023-2028年全球數位治療市場的預期成長率是多少？
  • 推動全球數位治療市場的關鍵因素是什麼？
  • COVID-19 對全球數位治療市場有何影響？
  • 基於應用的全球數位治療市場的詳細情形如何？
  • 根據最終用途，全球數位治療市場的詳細情形如何？
  • 全球數位治療市場的關鍵區域有哪些？
  • 誰是全球數位治療市場的主要參與者/公司？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球數位治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按應用分類的市場區隔

  • 糖尿病
    • 市場走向
    • 市場預測
  • 肥胖
    • 市場走向
    • 市場預測
  • CVD
    • 市場走向
    • 市場預測
  • 中樞神經系統疾病
    • 市場走向
    • 市場預測
  • 呼吸疾病
    • 市場走向
    • 市場預測
  • 戒菸
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：依最終用途分類的市場區隔

  • 患者
    • 市場走向
    • 市場預測
  • 供應商
    • 市場走向
    • 市場預測
  • 付款人
    • 市場走向
    • 市場預測
  • 雇主
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 2Morrow Inc.
    • Canary Health Inc.
    • Click Therapeutics Inc.
    • Mango Health Inc. (TrialCard Incorporated)
    • Noom Health Inc.
    • Omada Health Inc.
    • Pear Therapeutics, Inc.
    • Propeller Health (ResMed)
    • Teladoc Health Inc.
    • Voluntis Inc.
    • WellDoc Inc.
Product Code: SR112023A3889

Abstract

The global digital therapeutics market size reached US$ 5.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2028, exhibiting a growth rate (CAGR) of 20.1% during 2022-2028. The growing demand for digital behavior-monitoring treatment, increasing prevalence of chronic diseases, and rising awareness among the masses about personal health and fitness represent one of the key factors driving the market.

Increasing Usage of Smartphones and Tablets Propelling Market Growth

The rising reliance on smartphones and tablets, coupled with different healthcare apps, is propelling the growth of the digital therapeutics market. Smartphones and tablet-based healthcare apps have numerous advantages over the lower rate of medication errors, facilitating preventive care, and more accurate staffing. The increasing utilization of personal technological devices in healthcare is catalyzing the demand for digital therapeutics (DTx) treatments. DTx is enhancing patient access to the safety and effectiveness of treatments, presenting information in different languages, providing relevant information about diseases and treatments, and expanding the ability of physicians to care for patients. Furthermore, it is an advanced mode of care delivery, which can be easily implemented at home and eliminates any stigma associated with traditional therapies.

Digital Therapeutics Market Trends:

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of a large number of global and regional players. Moreover, the competitive environment in this market is intensifying due to the increasing number of research and development (R&D) innovations and mergers and acquisitions (M&A). The volume of new entrants is moderate in the digital therapeutics industry due to the fragmented market structure and low product differentiation and switching cost. In addition, the growing number of mhealth developers is contributing to the high threat of new entrants. However, the requirement of patents and high costs of advanced technologies along with stringent regulatory procedures, decreases the threat from new entrants.

What are Digital Therapeutics?

Digital therapeutics (DTx) is an evidence-based therapeutic intervention driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. It is a form of a software-as-a-medical device (SaMD) that relies on software interventions to bring about behavioral changes in patients and help treat their conditions. DTx is a fast-emerging class of therapies that utilizes software to treat disease as a standalone or for treatment optimization. It assists in preventing and managing a wide variety of diseases and conditions, such as type 2 diabetes, congestive heart failure, obesity, Alzheimer's disease, dementia, asthma, substance abuse, attention deficit hyperactivity disorder (ADHD), hypertension, anxiety, depression, and several others. DTx also aids in improving patient medication adherence and supporting healthcare professionals (HCPs) to manage their patients and businesses digitally.

COVID-19 Impact:

The arrival of the COVID-19 pandemic can be described as a watershed moment for the healthcare industry. It changed the manner of healthcare delivery dramatically while exposing the lack of preparedness on the part of governments worldwide to adequately tackle a global healthcare emergency. Frontline health workers were involved in managing COVID-19 patients, but patients with other health conditions, especially chronic health conditions, experienced difficulties as their in-clinic visits were postponed or avoided. Moreover, as the outcomes of COVID-19 among patients with comorbidities, especially obesity, heart complications, and diabetes, were worse than those without, these patients were asked to be additionally vigilant. The pandemic also brought a fair share of mental health disorders, including depression, anxiety, and withdrawals, and their management was a challenge due to the lack of face-to-face visits. These interconnected events have made healthcare providers look out for digital health solutions to tackle health crisis. There was a positive trend observed during the COVID-19 outbreak in relation to the adoption of digital health technologies, which increased the efficiency and effectiveness of healthcare operations and service delivery. After the pandemic started, the adoption of DTx applications in various fields accelerated many folds. Additionally, the COVID-19 pandemic increased the adoption of virtual and home care technologies by transforming patient engagement and integrating data across the healthcare landscape.

Digital Therapeutics Market Trends:

At present, there is a rise in the demand for DTx among type 2 diabetes patients to manage the disease and enable them to use the internet of things (IoT)-enabled insulin pumps and other health monitoring systems. This, along with the increasing demand for digital behavior-monitoring treatment to ensure medication adherence and healthy lifestyle changes, represents one of the key factors supporting the growth of the market. In addition, the growing utilization of DTx to reduce the need for more follow-up checkups and relapses compared to traditional treatments is offering a favorable market outlook. Moreover, there is an increase in the prevalence of chronic diseases, such as heart disease, stroke, cancer, obesity, and arthritis. This, coupled with the rising awareness among the masses about personal health and fitness, is propelling the growth of the market. Additionally, the escalating demand for DTx to help doctors manage patient adherence to medical regimens and build an integrated health ecosystem that can enable the seamless transfer of data between different stakeholders, such as payers, providers, and pharmacies, is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global digital therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on application and end use.

Application Insights:

Diabetes

Obesity

CVD

CNS Disease

Respiratory Diseases

Smoking Cessation

Others

The report has provided a detailed breakup and analysis of the digital therapeutics market based on the application. This includes diabetes, obesity, CVD, CNS disease, respiratory diseases, smoking cessation, and others. According to the report, diabetes represented the largest segment due to the rising prevalence of diabetes, along with the high risk of associated conditions, such as cardiac arrests, kidney failure, and blindness, in diabetic patients. Moreover, the growing integration of DTx with numerous medical devices, such as insulin pumps, glucose blood meters, and wearable gadgets, is positively influencing the market.

End Use Insights:

Patients

Providers

Payers

Employers

Others

A detailed breakup and analysis of the digital therapeutics market based on the end use has also been provided in the report. This includes patients, providers, payers, employers, and others. According to the report, patients accounted for the largest market share due to the rising adoption of DTx among patients for numerous associated benefits pertaining to elective health management at an affordable cost. In addition, the increasing consumer inclination towards patient management systems for improving retention and compliance with post hospitalization follow-up visits is catalyzing the demand for DTx.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for digital therapeutics. Some of the factors driving the North America digital therapeutics market included the growing geriatric population, continuous upgradations in drug approval processes by the Food and Drug Administration (FDA), rising awareness about the benefits of DTx, etc. In addition, the growing utilization of DTx as a standalone therapy or in conjunction with medications, devices, and other therapies to optimize patient care and healthcare outcomes is offering a favorable market outlook.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global digital therapeutics market. Some of the companies covered in the report include:

2Morrow Inc.

Canary Health Inc.

Click Therapeutics Inc.

Mango Health Inc. (TrialCard Incorporated)

Noom Health Inc.

Omada Health Inc.

Pear Therapeutics, Inc.

Propeller Health (ResMed)

Teladoc Health Inc.

Voluntis Inc.

WellDoc Inc.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global digital therapeutics market in 2022?
  • 2. What is the expected growth rate of the global digital therapeutics market during 2023-2028?
  • 3. What are the key factors driving the global digital therapeutics market?
  • 4. What has been the impact of COVID-19 on the global digital therapeutics market?
  • 5. What is the breakup of the global digital therapeutics market based on the application?
  • 6. What is the breakup of the global digital therapeutics market based on the end use?
  • 7. What are the key regions in the global digital therapeutics market?
  • 8. Who are the key players/companies in the global digital therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Diabetes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Obesity
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CVD
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CNS Disease
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Respiratory Diseases
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Smoking Cessation
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Patients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Providers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Payers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Employers
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 2Morrow Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Canary Health Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Click Therapeutics Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Mango Health Inc. (TrialCard Incorporated)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Noom Health Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Omada Health Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Pear Therapeutics, Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Propeller Health (ResMed)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Teladoc Health Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Voluntis Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 WellDoc Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Digital Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Therapeutics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Digital Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Digital Therapeutics Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Digital Therapeutics Market: Breakup by End Use (in %), 2022
  • Figure 6: Global: Digital Therapeutics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Digital Therapeutics (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Digital Therapeutics (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Digital Therapeutics (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Digital Therapeutics (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Digital Therapeutics (CVD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Digital Therapeutics (CVD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Digital Therapeutics (CNS Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Digital Therapeutics (CNS Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Digital Therapeutics (Respiratory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Digital Therapeutics (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Digital Therapeutics (Smoking Cessation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Digital Therapeutics (Smoking Cessation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Digital Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Digital Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Digital Therapeutics (Patients) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Digital Therapeutics (Patients) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Digital Therapeutics (Providers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Digital Therapeutics (Providers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Digital Therapeutics (Payers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Digital Therapeutics (Payers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Digital Therapeutics (Employers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Digital Therapeutics (Employers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Digital Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Digital Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: North America: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Asia-Pacific: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Asia-Pacific: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: China: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: China: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Japan: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Japan: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: India: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: India: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: South Korea: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: South Korea: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Australia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Australia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Indonesia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Indonesia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Europe: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Europe: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Germany: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Germany: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: France: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: France: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: United Kingdom: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: United Kingdom: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Italy: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Italy: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Spain: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Spain: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Russia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Russia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Latin America: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Latin America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Brazil: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Brazil: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Mexico: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Mexico: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Middle East and Africa: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Middle East and Africa: Digital Therapeutics Market: Breakup by Country (in %), 2022
  • Figure 79: Middle East and Africa: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Digital Therapeutics Industry: SWOT Analysis
  • Figure 81: Global: Digital Therapeutics Industry: Value Chain Analysis
  • Figure 82: Global: Digital Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Therapeutics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Digital Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 3: Global: Digital Therapeutics Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 4: Global: Digital Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Digital Therapeutics Market: Competitive Structure
  • Table 6: Global: Digital Therapeutics Market: Key Players